AliveCor announced today that the final determination rule on its patent dispute with Apple cleared presidential review. In December, the International Trade Commission (ITC) ruled that the Apple Watch infringed AliveCor’s patented technology. Along with its final determination, the ITC issued a limited exclusion disorder (LEO) and a cease and desist order. It set a […]
Patient Monitoring
Ascensia partners with Snaq on diabetes management
Ascensia Diabetes Care announced today that it entered into a global collaboration with diabetes management company Snaq. Snaq develops an app-based solution offering insights on food and nutrition for people with diabetes. Ascensia develops the Controu blood glucose monitoring system and distributes Senseonics’ Eversense CGM systems. The companies plan to integrate technologies to help with […]
Medicare to cover Dexcom G7 when it launches this week
Dexcom (Nasdaq:DXCM) announced today that Medicare offers coverage for its beneficiaries using the next-generation G7 CGM. The company announced the coming U.S. launch for G7 in a Super Bowl Commercial with musician Nick Jonas last night. It’s slated to roll out on Friday, Feb. 17. San Diego-based Dexcom met the category requirements for therapeutic continuous […]
Insulet acquires insulin pump patents from Bigfoot Biomedical for $25M
Insulet (Nasdaq:PODD) announced today that it acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technologies. Acton, Massachusetts-based Insulet paid $25 million to acquire the AID assets. These include certain Bigfoot patents related to pumps that may be used for AID therapy. Insulet already develops its own AID technology with its Omnipod platform. The […]
Abbott is bullish on FreeStyle Libre growth in 2023
Abbott (NYSE:ABT) plans to “go more aggressively” into the continuous glucose monitor (CGM) market with its FreeStyle Libre 3 this year. Chair and CEO Robert Ford said on the company’s most recent earnings call that the company expects growth for the platform this year. FreeStyle Libre 3 received FDA clearance in May 2022. Ford cited full-year growth […]
Dexcom stock rises after hours on Street-beating Q4
Dexcom (Nasdaq:DXCM) shares ticked up after the market closed today on fourth-quarter results that topped the consensus forecast. Shares of DXCM rose 2.2% at $109.61 apiece after hours. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 10.1%. The San Diego-based continuous glucose monitor […]
New medtech to watch for in 2023: boosting health outcomes
As earnings season is upon us, we’re receiving a clearer view of what new medtech could be launching this year in the medical device space. Companies still feel hamstrung by macroeconomic pressures, supply chain issues and more. However, many pointed out that 2023 has plenty to look forward to. Several quarterly reports and earnings calls […]
DarioHealth, Dexcom partner to integrate CGM into digital health platform
DarioHealth (Nasdaq:DRIO) announced today that it agreed with Dexcom (Nasdaq:DXCM) to integrate continuous glucose monitoring into its digital health platform. Dexcom CGM uses small, wearable sensors to continuously measure and send glucose levels to a receiver or smart device. The company’s latest CGM technology, the Dexcom G7, recently received FDA clearance. The company plans to […]
LivaNova starts limited European launch of perfusion system for cardiopulmonary bypass
LivaNova (Nasdaq:LIVN) announced today that it began a limited commercial release for its Essenz perfusion system in Europe. The company initiated its launch in select centers throughout Europe after successful implementation in The Netherlands and Italy. London-based LivaNova built the Essenz system with a next-generation heart-lung machine and a patient monitor. The company designed it […]
Dexcom to announce U.S. G7 launch in Super Bowl commercial with Nick Jonas
Dexcom (Nasdaq:DXCM) today unveiled its upcoming Super Bowl commercial that announces the U.S. launch of its next-generation Dexcom G7 CGM. The ad, set to run during the second quarter of Super Bowl LVII on Feb. 12, features musician, actor and philanthropist Nick Jonas. Jonas lives with type 1 diabetes and uses Dexcom’s continuous glucose monitors […]
Sensydia completes enrollment in study for AI-powered cardiac monitoring device
Sensydia announced today that it completed enrollment in its 225-subject development study for its AI-powered Cardiac Performance System (CPS). Los Angeles-based Sensydia designed the AI-based, non-invasive CPS to use heart sound analysis. It may enable earlier detection and improved therapy guidance for heart failure and pulmonary hypertension patients. CPS uses ultra-sensitive biosensors for the rapid, […]